Zheng, Yi-Hu <br/><br/>
BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  12 2016 
 - 1836-1847 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/liv.13178  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>China<br/>Cisplatin--pharmacology<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Middle Aged<br/>Prognosis<br/>Proto-Oncogene Proteins c-myc--genetics<br/>RNA, Small Interfering--genetics<br/>Transaminases--genetics<br/>Xenograft Model Antitumor Assays